Retraction notice to “miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1” [Biomed. Pharmacother. 106 (2018) 1072–1081]

• Huixing Deng,
• Qianqian Geng,
• Ting Ji,
• Aimin Yang

Affiliations

Huixing Deng

Department of Nuclear Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China

Qianqian Geng

Department of Nuclear Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China

Ting Ji

Department of Nuclear Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China

Aimin Yang

Corresponding author.; Department of Nuclear Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China